Table 4 Sensitivity analysis after excluding participants who occurred cancer within the first year and the first five years of follow-up.
From: The relationship between serum uric acid and colorectal cancer: a prospective cohort study
Groups | Cases/person-years | Adjusted models | |
|---|---|---|---|
HR (95%CI) | p-value | ||
Exclude CRC cases diagnosed within the first year of follow-up | |||
T1 group | 153/385,550 | Ref | |
T2 group | 178/383,401 | 1.09 (0.88, 1.68) | 0.655 |
T3 group | 224/373,103 | 1.57 (1.11, 2.31) | 0.014 |
P for trend | 0.001 | ||
Exclude CRC cases diagnosed within the first 5 year of follow-up | |||
T1 group | 68/385,252 | Ref | |
T2 group | 90/383,063 | 1.22 (0.92, 2.39) | 0.351 |
T3 group | 140/372,806 | 2.01 (1.58, 2.89) | < 0.001 |
P for trend | < 0.001 | ||